The Longevity Biomarker Company
A Little History Behind Our Enterprise
Jinfiniti is a scientist led, data driven company that is dedicated to empowering clinicians and individuals to optimize their health, performance and longevity. Jinfiniti does this by developing and analyzing unique and actionable biomarkers. Therefore, Jinfiniti has the unique ability to develop clinically proven interventions that will correct the discovered sub-health issues for the prevention of age-related diseases and improve efficacy of treatment.
The company was founded by a team of scientists with highly successful academic careers with a desire to bring powerful and positive change to the health and longevity field by developing a number of innovative biomarkers that are not available anywhere else in the world. Their work quickly attracted a team of highly experienced and very passionate entrepreneurs, who now serve as senior executives. Together we can now offer testing, personalized interventions and evaluation of treatment outcomes to clinicians and individuals around the world.
All tests are done in our own high-complexity CLIA laboratory (CLIA ID #: 11D2264938) located in the beautiful Golf Capital, Augusta, Georgia. The laboratory is directed and managed by a highly skilled team of clinicians and scientists. The laboratory can run most routine clinical tests but specializes in developing and implementing Laboratory Developed Tests (LDTs) that are not available anywhere else in the world.
Management Team
Dr. Jin-Xiong She received his college education in China and PhD degree in France. After a short postdoctoral training at the University of Florida (UF), he was quickly promoted to Assistant Professor, Associate Professor, Full and Endowed Professor. He served as Division Chief of Experimental Pathology and Director of Research of the UF’s world-class Diabetes Center. Dr. She was recruited in 2002 to be the Georgia Research Alliance Eminent Scholar in Genomic Medicine at the Medical College of Georgia. He was the founding Director of the Center for Biotechnology and Genomic Medicine, Professor of the Departments of Obstetrics and Gynecology and Department of Health Technologies as well as the director of two core research facilities for Augusta University (Genomics, Proteomics & Mass Spectrometry). In his long academic career, he has authored over 400-peer reviewed papers with an H-Index of 76 and over 19,000 citations, secured over $100 million in research grants, has been invited to speak globally. He mentored a large number of doctoral students, post-docs and faculty members. Dr. She is one of the 20 “Georgia Top Medical Researchers”. He served as President of the Chinese Geneticists in America and President of the American Diabetes Association’s council on Immunology, transplantation and Immunogenetics among other honors. Dr. She is a serial entrepreneur and has founded or co-founded multiple companies in the US and China. He is the founder and CEO of Jinfiniti Precision Medicine, a company dedicated to optimizing healthspan through biomarker testing and precision nutraceuticals. More information can be found on Jin-Xiong She’ LinkedIn Profile and Jin-Xiong She’s Google Scholar Profile.
Becoming The Next Big Thing
Press
JPM wins the 20 Most Innovative Companies to Watch awards | Business Worldwide Magazine | 01/31/2022 | Read more | |
JPM named as top leader in longevity biomarkers | Longevity International | 04/12/2022 | Read more | |
Jinfiniti Precision Medicine Founder Jin Xiong She talks about NAD optimization | Aging Analytics Agency | 04/12/2022 | Read more |